--- title: "Deloitte: In the first quarter, A-share IPO financing increased by 59%, with more than half of the listings on the Beijing Stock Exchange" type: "News" locale: "en" url: "https://longbridge.com/en/news/282106874.md" description: "Deloitte released a report showing that in the first quarter of 2026, both the number of A-share IPOs and the financing scale achieved double-digit growth, with 30 new stocks listed and raising 25.9 billion yuan, an increase of 59% compared to the same period in 2025. The Beijing Stock Exchange accounted for more than half of the IPOs, reaching 16 companies. The Shanghai Stock Exchange had the highest financing amount, with 10 new stocks raising 15.4 billion yuan. The number of A-share IPO applications increased, with 299 companies applying for listing" datetime: "2026-04-08T23:20:28.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282106874.md) - [en](https://longbridge.com/en/news/282106874.md) - [zh-HK](https://longbridge.com/zh-HK/news/282106874.md) --- # Deloitte: In the first quarter, A-share IPO financing increased by 59%, with more than half of the listings on the Beijing Stock Exchange On April 8, Deloitte China's Capital Markets Services Department (hereinafter referred to as "Deloitte") released a latest report showing that in the first quarter of 2026, the number of IPOs and the financing scale of A-shares both experienced double-digit growth year-on-year (compared to the same period last year). Deloitte pointed out that in the first quarter of 2026, a total of 30 new stocks were listed in the A-share market, raising a total of 25.9 billion yuan, compared to 27 new stocks raising 16.3 billion yuan in the same period of 2025, with the number of IPOs increasing by 11% and the financing amount growing by 59%. Specifically, in terms of the number of IPOs, the Beijing Stock Exchange (hereinafter referred to as "BSE") ranked first with a total of 16; the Shanghai Stock Exchange (hereinafter referred to as "SSE") followed closely with 6 on the Sci-Tech Innovation Board and 4 on the Main Board; the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") had 2 on both the Main Board and the ChiNext. In terms of financing amounts, the SSE ranked first, with 10 new stocks raising a total of 15.4 billion yuan; the SZSE followed with 4 new stocks raising a total of 5.6 billion yuan; the BSE ranked next with 16 new stocks raising a total of 4.9 billion yuan. Regarding average financing scale, Deloitte stated that in the first quarter of 2026, the average financing scales for the SSE Main Board, SZSE Main Board, Sci-Tech Innovation Board, and ChiNext were 1.61 billion yuan, 1.16 billion yuan, 1.49 billion yuan, and 1.66 billion yuan, respectively, all showing growth compared to the average financing scales of 740 million yuan, 550 million yuan, 640 million yuan, and 600 million yuan in the same period last year. However, in the first quarter of this year, the average financing scale of the BSE was 310 million yuan, a decrease from 460 million yuan in the same period last year. At the same time, Deloitte pointed out that in the first quarter of 2026, the number of IPOs and applications for A-shares both increased compared to last year. In terms of IPO meetings, there were a total of 46 new stocks in A-shares that attended meetings in the first quarter, with 33 from the BSE, 4 each from the Sci-Tech Innovation Board and ChiNext, 3 from the SZSE Main Board, and 2 from the SSE Main Board. In terms of IPO applications, a total of 299 companies applied for listing in A-shares in the first quarter, with 34 from the SSE and SZSE Main Boards, including 18 from the SSE Main Board and 16 from the SZSE Main Board; there were 43 from the Sci-Tech Innovation Board, 37 from ChiNext, and 185 from the BSE. At the same time, there are currently 163 companies with IPOs under review that have been suspended, pending the update of financial reports for resumption of review. Among them, there are 105 from the BSE, 19 each from the Sci-Tech Innovation Board and ChiNext, 12 from the SZSE Main Board, and 8 from the SSE Main Board. As of March 31, 2025, there were 136 active applications under processing in A-shares, including 80 from the BSE, 24 from the Sci-Tech Innovation Board, 18 from ChiNext, and 10 and 4 from the SSE and SZSE Main Boards, respectively 7 companies have passed the review, all listed on the Beijing Stock Exchange; 17 companies have submitted registration, with 12 on the Beijing Stock Exchange, 3 on the Sci-Tech Innovation Board, and 1 each on the Shanghai and Shenzhen main boards; there are 32 companies that have registered and become effective but have not yet issued, with 14 on the Beijing Stock Exchange, 7 on the ChiNext, 5 on the Shenzhen main board, and 3 each on the Shanghai main board and the Sci-Tech Innovation Board. Deloitte stated that in the first quarter of 2026, the A-share IPO market will show growth in terms of financing scale, number of new shares, number of companies applying for listing, and number of reviews compared to the first quarter of 2025, mainly benefiting from various capital market reform measures. Looking ahead, Deloitte expects that with the approval of listing applications and the normalization of new share issuance, the advancement of reforms on the ChiNext and Sci-Tech Innovation Board, as well as the inflow of long-term investment funds such as insurance funds into the stock market, the A-share IPO market is expected to maintain its growth momentum. Zhao Haizhou, partner in charge of A-share listing business in East China at Deloitte China Capital Markets Services, stated: "In the first quarter of 2026, the number of new shares and financing amounts in the A-share market have surpassed the levels of the first quarters of 2025 and 2024, indicating that the IPO market is further warming up. At the same time, given that some potential large listing companies have submitted listing applications, we are optimistic that the A-share IPO market will perform well in 2026." "Among them, companies in key strategic fields such as AI, new energy, high-end manufacturing, as well as aerospace, quantum technology, and biomanufacturing mentioned in the 14th Five-Year Plan will enjoy significant advantages when going public," Zhao Haizhou further pointed out ### Related Stocks - [159903.CN](https://longbridge.com/en/quote/159903.CN.md) - [399001.CN](https://longbridge.com/en/quote/399001.CN.md) - [399310.CN](https://longbridge.com/en/quote/399310.CN.md) - [000001.CN](https://longbridge.com/en/quote/000001.CN.md) - [510050.CN](https://longbridge.com/en/quote/510050.CN.md) - [510330.CN](https://longbridge.com/en/quote/510330.CN.md) - [399006.CN](https://longbridge.com/en/quote/399006.CN.md) - [159915.CN](https://longbridge.com/en/quote/159915.CN.md) - [563350.CN](https://longbridge.com/en/quote/563350.CN.md) - [000300.CN](https://longbridge.com/en/quote/000300.CN.md) - [000016.CN](https://longbridge.com/en/quote/000016.CN.md) ## Related News & Research - [China April Retail Sales +0.2% y/y (exp 2%) & Industrial Prduction +4.1% y/y (exp 5.9%)](https://longbridge.com/en/news/286699672.md) - [New Home Prices Rise, Hold Steady in Five More Major Chinese Cities in April](https://longbridge.com/en/news/286849542.md) - [China economy slows sharply as investment returns to contraction](https://longbridge.com/en/news/286707036.md) - [China's property investment extends decline in January-April](https://longbridge.com/en/news/286699189.md) - [China new home prices fall at slowest monthly pace in a year in April](https://longbridge.com/en/news/286697169.md)